Showing results (6431-6440 of 44,551) with videos related to
Sort By:
Pageof 4,456
BMJ Open|March 10, 2022
Prevalence and predictors of drug-related hospitalisation among patients visiting emergency departments of Addis Ababa city hospitals in Ethiopia: a multicentre prospective observational studyMulate Belete Demessie, Alemseged Beyene BerhaBMJ Open|March 10, 2022
Behavioural approaches to recruitment and retention in clinical trials: a systematic mapping reviewTaylor Coffey, Eilidh M Duncan, Heather Morgan, et al.BMJ Open|March 10, 2022
What is the healthcare utilisation and out-of-pocket expenditure associated with osteoarthritis? A cross-sectional studyDavid Sibbritt, Tobias Sundberg, Lesley Ward, et al.BMJ Open|March 10, 2022
Telerehabilitation for lower extremity recovery poststroke: a systematic review and meta-analysis protocolSarah Park, Ada Tang, Courtney Pollock, et al.BMJ Open|March 10, 2022
Early mobilisation using a mobile patient lift in the intensive care unit: protocol for a randomised controlled trialGinga Suzuki, Hiromi Kanayama, Ryo Ichibayashi, et al.BMJ Open|March 10, 2022
Improving the mental health and mental health support available to adolescents with social care-experience via low-intensity life story work: a realist review protocolSimon P Hammond, Claire Duddy, Ella Mickleburgh, et al.BMJ Open|March 5, 2022
Correlates of time to clinical presentation for symptomatic individuals with gonorrhoea in South China: results from a cross-sectional studyPeizhen Zhao, Juan Nie, Huanhuan Cheng, et al.BMJ Open|March 5, 2022
Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trialAudinga-Dea Hazewinkel, Carlo Lancia, Jakob Anninga, et al.BMJ Open|March 5, 2022
Effectiveness and cost-effectiveness of a combined lifestyle intervention compared with usual care for patients with early-stage knee osteoarthritis who are overweight (LITE): protocol for a randomised controlled trialNuria E J Jansen, Dieuwke Schiphof, Edwin Oei, et al.BMJ Open|March 5, 2022
Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trialTobias Menne, Daniel Slade, Joshua Savage, et al.Pageof 4,456